BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1176 related articles for article (PubMed ID: 18334831)

  • 81. Outcome of right- and left-sided colonic and rectal cancer following surgical resection.
    Suttie SA; Shaikh I; Mullen R; Amin AI; Daniel T; Yalamarthi S
    Colorectal Dis; 2011 Aug; 13(8):884-9. PubMed ID: 20594201
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer.
    Jullumstrø E; Lydersen S; Møller B; Dahl O; Edna TH
    Eur J Cancer; 2009 Sep; 45(13):2383-90. PubMed ID: 19356923
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer.
    Ishida H; Miwa H; Tatsuta M; Masutani S; Imamura H; Shimizu J; Ezumi K; Kato H; Kawasaki T; Furukawa H; Kawakami H
    Cancer Lett; 2004 Apr; 207(1):109-15. PubMed ID: 15050740
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study].
    Zhou ZW; Wan DS; Wang GQ; Pan ZZ; Lu HP; Gao JH; Ding PR
    Ai Zheng; 2004 Jul; 23(7):851-4. PubMed ID: 15248927
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer.
    Sundov Z; Tomic S; Alfirevic S; Sundov A; Capkun V; Nincevic Z; Nincevic J; Kunac N; Kontic M; Poljak N; Druzijanic N
    Hepatogastroenterology; 2013 May; 60(123):432-8. PubMed ID: 23321007
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
    Boye K; Nesland JM; Sandstad B; Mælandsmo GM; Flatmark K
    Eur J Cancer; 2010 Nov; 46(16):2919-25. PubMed ID: 20719498
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer.
    Zlobec I; Höller S; Tornillo L; Terracciano L; Lugli A
    Dis Colon Rectum; 2009 Jun; 52(6):1114-21. PubMed ID: 19581855
    [TBL] [Abstract][Full Text] [Related]  

  • 89. MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
    Bendardaf R; Buhmeida A; Hilska M; Laato M; Syrjänen S; Syrjänen K; Collan Y; Pyrhönen S
    Cancer Invest; 2010 Jan; 28(1):38-43. PubMed ID: 20001295
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Factors affecting the prognosis and selection of local excision for low rectal cancer].
    Hang JW; Zhou ZX; Bu YQ; Bai XF; Wang X; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):141-3. PubMed ID: 17645854
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
    Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
    Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Matrix metalloproteinase-2 expression and its correlation with mesorectal metastasis in middle and lower rectal cancer].
    Wan J; Wu ZY; Lin HH; Luo XL; Zhang W; Du JL; Yao Y; Wang ZD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):136-8. PubMed ID: 16555154
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Correlation between the results of carcinoembryonal antigen (CEA) test and the clinical stage of colorectal carcinoma.
    Molnár L; Rahóty P; Bauer E; Rónay P; Besznyák I; Ottó S
    Acta Chir Hung; 1986; 27(1):27-34. PubMed ID: 3716715
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical significance of chicken ovalbumin upstream promoter-transcription factor II expression in human colorectal cancer.
    Shin SW; Kwon HC; Rho MS; Choi HJ; Kwak JY; Park JI
    Oncol Rep; 2009 Jan; 21(1):101-6. PubMed ID: 19082449
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prognostic factors in survival of colorectal cancer patients after surgery.
    Mehrkhani F; Nasiri S; Donboli K; Meysamie A; Hedayat A
    Colorectal Dis; 2009 Feb; 11(2):157-61. PubMed ID: 18462239
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Influence of family history on survival in patients with colon and rectal cancer.
    Lee SD; Kim BC; Han KS; Hong CW; Sohn DK; Park JW; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Mar; 15(3):108-15. PubMed ID: 24304621
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Preoperative carcinoembryonic antigen and prognosis in patients with colorectal cancer.
    Onetto M; Paganuzzi M; Secco GB; Fardelli R; Santi F; Rovida S; Ferrara GB
    Biomed Pharmacother; 1985; 39(7):392-5. PubMed ID: 3830268
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis.
    Wray CM; Ziogas A; Hinojosa MW; Le H; Stamos MJ; Zell JA
    Dis Colon Rectum; 2009 Aug; 52(8):1359-66. PubMed ID: 19617745
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
    Schwandner O; Schlamp A; Broll R; Bruch HP
    Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.